Cargando…

Sustained Mild Inflammation in Cancer Survivors: Where to from Here?

Detalles Bibliográficos
Autores principales:	Walker, Adam K, Chan, Raymond J, Vardy, Janette L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Solicited Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420042/ https://www.ncbi.nlm.nih.gov/pubmed/35900189 http://dx.doi.org/10.1093/jncics/pkac054

Ejemplares similares

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Does as Little as Two Hours a Day of Television Viewing Increase the Risk of Young-Onset Colorectal Cancer?
por: Vardy, J, et al.
Publicado: (2019)

Long-Term Cancer Survival: New Insights From Health Professional Cohorts
por: Samet, Jonathan M, et al.
Publicado: (2022)

Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE
por: Gong, Jun, et al.
Publicado: (2022)

Robot- vs Video-Assisted Thoracoscopic Lobectomy for Early Lung Cancer
por: Raman, Vignesh, et al.
Publicado: (2020)

Making Breast Cancer Molecular Subtypes Robust?
por: Staaf, Johan, et al.
Publicado: (2014)

On the Black–White Disparity in Prostate Cancer Mortality
por: Brawley, Otis W, et al.
Publicado: (2021)

Challenges in Predicting Future Costs for Metastatic Breast Cancer
por: Dinan, Michaela A, et al.
Publicado: (2021)

Towards Better Understanding of COVID-19 Infection in Cancer Patients
por: Hoffmann, Marc S
Publicado: (2020)

More Questions Than Answers for Adolescents and Young Adults With Cancer
por: Seibel, Nita L, et al.
Publicado: (2021)

Physical Activity to Improve Lung Cancer Survival: Promising Evidence
por: Friedenreich, Christine M, et al.
Publicado: (2022)

Refining Risk Estimates in Hereditary Nonpolyposis Colorectal Cancer: Are We There Yet?
por: Lynch, Patrick M, et al.
Publicado: (2020)

Toward Understanding the Etiology of Male Breast Cancer: An Ongoing Research Challenge
por: Zeinomar, Nur, et al.
Publicado: (2021)

Prevention of Early-Onset Colorectal Cancer: Not One Size Fits All
por: Otegbeye, Ebunoluwa E, et al.
Publicado: (2021)

Should Complex Cancer Patients Requiring High-Risk Surgery Shoot for the Stars?
por: Dossa, Fahima, et al.
Publicado: (2020)

A Feasible Path to Reductions in Racial and Ethnic Disparities in Lung Cancer Screening?
por: Ritzwoller, Debra P
Publicado: (2022)

Obesity and Risk of Liver and Biliary Tract Cancer: Does Timing and Trajectory Matter?
por: Befort, Christie A, et al.
Publicado: (2022)

Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations
por: Pacheco, Jose, et al.
Publicado: (2021)

The Long Red Line: Breast Cancer Incidence at the Intersection of Unjust Structural Policies and Their Contemporary Manifestations
por: McCullough, Lauren E
Publicado: (2022)

A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only Sequencing
por: Ceyhan-Birsoy, PhD, Ozge, et al.
Publicado: (2020)

A Call to Action: “Low-Dose Radiation May Help Cure COVID-19…” [Taps Mic] “…Is This Thing On?”
por: Khan, Mohammad K, et al.
Publicado: (2020)

The Value of Helicobacter Eradication in Long-term Aspirin Users
por: Cuzick, Jack
Publicado: (2018)

When Should Oncologists Use the Words Hope and Cure?
por: Kiely, Belinda E, et al.
Publicado: (2020)

Sugar-Sweetened Beverage Taxes Are a Sweet Deal: Improve Health, Save Money, Reduce Disparities, and Raise Revenue
por: Ward, Zachary J, et al.
Publicado: (2020)

Small Steps and Giant Leaps or Just Getting on With It?
por: Davis, Ian D
Publicado: (2021)

Screening for Neuroblastoma Using Urinary Catecholamines: The End of the Story
por: Woods, William G
Publicado: (2021)

The Increasing Importance of Rigorous Real-World Evidence
por: Yang, David D, et al.
Publicado: (2022)

Kaposi Sarcoma in the United States: Understanding Disparate Risk
por: Reiner, Anne S, et al.
Publicado: (2022)

From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
por: Lieu, Christopher H., et al.
Publicado: (2013)

From here…… where and how?
por: Gopikrishna, Velayutham
Publicado: (2009)

Immunogenicity of two different hepatitis B vaccine schedules
por: Agladioglu, S. Y., et al.
Publicado: (2011)

A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
por: Bruno, Antonino, et al.
Publicado: (2014)

Deciphering the tRNA-dependent lipid aminoacylation systems in bacteria: Novel components and structural advances
por: Fields, Rachel N., et al.
Publicado: (2017)

Celebrating wobble decoding: Half a century and still much is new
por: Agris, Paul F., et al.
Publicado: (2017)

Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion
por: Young, Adelaide IJ, et al.
Publicado: (2017)

In Defense of P Values
por: Begg, Colin B
Publicado: (2020)

WHERE DO WE GO FROM HERE?
por: Kuruvilla, K.
Publicado: (1994)

Ayurvedic education: Where to go from here?
por: Manohar, P. Ram
Publicado: (2014)

Covid-19 Boosters — Where from Here?
por: Offit, Paul A.
Publicado: (2022)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s90ef43h6vspm11japq8idfkdo